Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Immunology and Cell Biology
|
November 17, 2010
Shaping the T-cell repertoire in the periphery
Stacey Allen, Stephen J Turner, Dorothée Bourges, et al.
Oncoimmunology
|
May 10, 2019
Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome
Jing Liu, Jake S O'Donnell, Juming Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 2005
Promiscuous thymic expression of an autoantigen gene does not result in negative selection of pathogenic T cells
Stacey Allen, Simon Read, Richard DiPaolo, et al.
Oncoimmunology
|
June 7, 2018
RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer
Elizabeth Ahern, Heidi Harjunpää, Jake S O'Donnell, et al.
Oncoimmunology
|
February 5, 2019
Batf3<sup>+</sup> DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy
Jing Liu, Elisa A Rozeman, Jake S O'Donnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 25, 2014
Transient systemic inflammation does not alter the induction of tolerance to gastric autoantigens by migratory dendritic cells
Dorothée Bourges, Ellen M Ross, Stacey Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2017
Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice
Elizabeth Ahern, Heidi Harjunpää, Deborah Barkauskas, et al.
Cancer Immunology Research
|
June 21, 2018
Experimental Lung Metastases in Mice Are More Effectively Inhibited by Blockade of IL23R than IL23
Juming Yan, Stacey Allen, Dipti Vijayan, et al.
Cancer Research
|
August 10, 2016
Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer
Jing Liu, Stephen J Blake, Heidi Harjunpää, et al.
Cancer Discovery
|
September 25, 2016
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
Jing Liu, Stephen J Blake, Michelle C R Yong, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Immunology and Cell Biology
|
November 17, 2010
Shaping the T-cell repertoire in the periphery
Stacey Allen, Stephen J Turner, Dorothée Bourges, et al.
Oncoimmunology
|
May 10, 2019
Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome
Jing Liu, Jake S O'Donnell, Juming Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 2005
Promiscuous thymic expression of an autoantigen gene does not result in negative selection of pathogenic T cells
Stacey Allen, Simon Read, Richard DiPaolo, et al.
Oncoimmunology
|
June 7, 2018
RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer
Elizabeth Ahern, Heidi Harjunpää, Jake S O'Donnell, et al.
Oncoimmunology
|
February 5, 2019
Batf3<sup>+</sup> DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy
Jing Liu, Elisa A Rozeman, Jake S O'Donnell, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 25, 2014
Transient systemic inflammation does not alter the induction of tolerance to gastric autoantigens by migratory dendritic cells
Dorothée Bourges, Ellen M Ross, Stacey Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2017
Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice
Elizabeth Ahern, Heidi Harjunpää, Deborah Barkauskas, et al.
Cancer Immunology Research
|
June 21, 2018
Experimental Lung Metastases in Mice Are More Effectively Inhibited by Blockade of IL23R than IL23
Juming Yan, Stacey Allen, Dipti Vijayan, et al.
Cancer Research
|
August 10, 2016
Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer
Jing Liu, Stephen J Blake, Heidi Harjunpää, et al.
Cancer Discovery
|
September 25, 2016
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
Jing Liu, Stephen J Blake, Michelle C R Yong, et al.
Page
of 2